Responsible for managing Pfizer I&I portfolio in Saudi (Xeljanz, Enbrel, Biosimilars, Dermatology). To profitably grow I&I franchise through team guidance and facilitating key functions and processes.Portfolio management across brands from pre-launch to LoE. Ensure high quality launches for new assets across I&I approved indications (RA, SpA, Ulcerative Colitis JIA, Atopic Dermatitis and Alopecia Areata). Evaluate current competition landscape and potential… Show more Responsible for managing Pfizer I&I portfolio in Saudi (Xeljanz, Enbrel, Biosimilars, Dermatology). To profitably grow I&I franchise through team guidance and facilitating key functions and processes.Portfolio management across brands from pre-launch to LoE. Ensure high quality launches for new assets across I&I approved indications (RA, SpA, Ulcerative Colitis JIA, Atopic Dermatitis and Alopecia Areata). Evaluate current competition landscape and potential opportunities/threats.Building close contact with Health Care authorities, specialists, registration offices, associations, GO/NGO key stakeholders.Maximize revenue and IBT performance through P&L management. Guide and prepare the creation of Brand Plans. Creating strategic plans for the Inflammation Franchise.Ensures all staff receives adequate training to enable superior performance.Develop and maintain rapport with KOLs to identify trends, competitor activities and new business opportunities.Establishing marketing concepts through setting the proper strategies and approaches with all stakeholders. Develop innovative business models to maximize revenue, market share, and IBT. Develop and implement innovative partnership projects that leverage existing capabilities & opportunities. Ensure optimal resources allocation for the attainment of business objectives. Identify and share insights on Saudi initiatives, challenges and opportunities.Navigating with the Inflammation Business Unit to exceed the defined sales, profit and market share objectives with directing and motivating the sales team towards the same objectives. Develop, with the cross-functional team, the annual strategic marketing/operational plan outlines. Managing sales & revenue analysis and supply forecasts to monitor market demand progress.Managing communication within matrix organization for flawless execution of tactical plans.Ensure plans/strategies accommodate the changes taking place in market and respond to customer needs. Show less

Responsible for growing Enbrel in both Psoriasis and Spondylo-Arthropathies (SpA) indications:Marketing role in the Saudi Rheumatology and Dermatology biologic domain through developing the marketing campaigns, commercial messages, field force induction training, KOLs engagement, supporting marketing programs in both Ankylosing Spondylitis (AS) and Psoriasis (PsO), strengthened with strong accessibility to key stakeholders and business partners (MOH medical supplies, GO-HC organizations… Show more Responsible for growing Enbrel in both Psoriasis and Spondylo-Arthropathies (SpA) indications:Marketing role in the Saudi Rheumatology and Dermatology biologic domain through developing the marketing campaigns, commercial messages, field force induction training, KOLs engagement, supporting marketing programs in both Ankylosing Spondylitis (AS) and Psoriasis (PsO), strengthened with strong accessibility to key stakeholders and business partners (MOH medical supplies, GO-HC organizations and societies, P&T Committees and KOLs). Show less

Commercial and sales experience promoting/launching Enbrel in all Institutional, MOH and Private hospitals in KSA:MOH Hospitals in western and central regions of KSA (Jeddah, Makkah, Taif, Gurayat, Tabuk, Yanbo’o, Najran and Jizan)Military Hospitals (Al-Hada Military hospital, KFAFH-Jeddah, NWAFH-Tabuk and Najran Military).Five Specialized Institutional Hospitals (KAAUH-Jeddah, KAMC-Makkah, SMS-Jeddah, KFSH-Riyadh, KFSH-Jeddah)Eight Major Private Hospitals (SFH, SGH, Bakhsh… Show more Commercial and sales experience promoting/launching Enbrel in all Institutional, MOH and Private hospitals in KSA:MOH Hospitals in western and central regions of KSA (Jeddah, Makkah, Taif, Gurayat, Tabuk, Yanbo’o, Najran and Jizan)Military Hospitals (Al-Hada Military hospital, KFAFH-Jeddah, NWAFH-Tabuk and Najran Military).Five Specialized Institutional Hospitals (KAAUH-Jeddah, KAMC-Makkah, SMS-Jeddah, KFSH-Riyadh, KFSH-Jeddah)Eight Major Private Hospitals (SFH, SGH, Bakhsh GH, Bagedo & Erfan, HJH, Bugshan, GNP, United Doctors)• 2011 achievement of 121% vs. TGT – Pfizer KSA• 2010 achievement of 118 % vs. TGT – Pfizer KSA• 2009 Achievement of 105% vs. TGT- Wyeth KSA• 2008 Achievement of 102 % vs. TGT - Wyeth KSA Show less

Promoting Bone line brands: Diclac® (Diclofenac Sodium), Lorano® (Loratadine) and Servivit-Plus® (Multi-Vitamin)Territory: Northern region of Cairo.

Promoting Cardio Vascular line brands: Amaryl® and Tritace® Territory: Giza City.